W
EW icon

WealthCollab’s Edwards Lifesciences EW Stock Holding History

WealthCollab’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.4K Sell
214
-13
-6% -$1.09K 0.01% 425
2026
Q1 		$18.2K Hold
227
– – 0.01% 394
2025
Q4 		$19.4K Hold
227
– – 0.01% 407
2025
Q3 		$17.7K Buy
227
+13
+6% +$1.02K 0.01% 384
2025
Q2 		$16.7K Buy
214
+104
+95% +$7.76K 0.01% 367
2025
Q1 		$7.97K Buy
110
+53
+93% +$3.79K ﹤0.01% 514
2024
Q4 		$4.22K Hold
57
– – ﹤0.01% 626
2024
Q3 		$3.76K Buy
+57
New +$4.14K ﹤0.01% 670

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

WealthCollab's EW Position: Q2 2026 in Review

WealthCollab reduced its Edwards Lifesciences (EW) stake by 5.7% in Q2 2026, selling an estimated $1.09K and leaving 214 shares worth $19.4K. The position accounts for 0.01% of the portfolio, ranked #425.

WealthCollab first reported a position in EW in Q3 2024 and has held it in 8 quarters since. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • WealthCollab held 214 shares of Edwards Lifesciences worth $19.4K as of Q2 2026.
  • WealthCollab sold 13 Edwards Lifesciences shares in Q2 2026, an estimated $1.09K.
  • Edwards Lifesciences made up 0.01% of WealthCollab's portfolio in Q2 2026, its #425 holding.
  • WealthCollab first reported a position in Edwards Lifesciences in Q3 2024 and has held it in 8 quarters since.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.